Let’s Compare: Kloxxado® vs Narcan®

Let’s Compare: Kloxxado® vs Narcan®2023-07-27T16:39:38-04:00

Comparing Kloxxado® (naloxone HCl) nasal spray 8 mg vs Narcan® (naloxone HCl) Nasal Spray 4 mg and Other Naloxone Offerings

Drug overdose is the leading cause of accidental death in the US, and the majority involve opioids.1 Illicitly manufactured fentanyl, a synthetic opioid which is 50 times stronger than heroin, is a major contributor to this wave of opioid overdose deaths.2 A fentanyl overdose can set in within minutes or even seconds.3,4 More than 150 people die each day from overdoses involving illicitly manufactured synthetic opioids like fentanyl.2

Medicines containing naloxone can safely reverse opioid overdose—even overdoses that involve fentanyl.5 Naloxone does this by attaching to the opioid receptors in the brain to stop the effects of opioids.6 This can help the person start breathing again.6 A naloxone nasal spray, such as Kloxxado® (naloxone HCl) nasal spray 8 mg, can be given to an overdose victim right at the scene by anyone—even if they have no medical training.7,8 Injectable forms of naloxone are available as well.9-11

Forty percent of fatal overdoses occur with someone nearby.12 If you come across someone experiencing an opioid overdose, and you’re carrying naloxone, you may be able to save that person’s life.5 (Click here to learn more about how to recognize an opioid overdose emergency.)

Naloxone is available in many forms, including Kloxxado® and 4 others shown below.7-11 If you’re thinking about carrying naloxone, here is a side-by-side comparison with Kloxxado® so you can decide which one(s) you would feel most comfortable giving in an emergency.

40%

of fatal overdoses occur with someone nearby.12

Accidental opioid overdose is more common than you think

Accidental drug overdose is the leading cause of accidental death in the US. Most of these involve opioids.3

Opioid medications used for pain are generally safe when taken for a short time and accounting for your own risk factors as prescribed by a doctor.2 But accidents can happen. You could accidentally take more than recommended. Your medicines may interact in ways you didn’t expect. You may have a medical condition that puts you at more risk than you thought. Someone could get into your medicine cabinet.4

The Bottom Line: Accidents Happen

Just like you wear your seatbelt and keep a fire extinguisher in your home, having Kloxxado® (naloxone HCl) nasal spray 8 mg in your first aid kit is a simple safety measure that could save your life.

Let your household members and friends know where to find Kloxxado® so they can help you in case of an emergency.

How to recognize an opioid overdose emergency

During an opioid overdose breathing can decline drastically or stop, causing brain damage and death. Check for the following signs of an opioid overdose so you can act fast:

Person will not wake up and does not respond to your voice or touch

Breathing is very slow, irregular, or has stopped

Center part of their eye is very small, also known as “pinpoint pupils”

Take control of your safety. Talk to your doctor about your risk factors. Be ready with Kloxxado®.

A bystander was present for nearly 40% of fatal overdoses.6

Take action right away

Take action if you suspect an opioid overdose emergency, even if you’re not sure. It could save someone’s life.

Administer Naloxone

Naloxone is a life-saving medication that counters the effects of an opioid overdose.

Call 911

Explain that someone is not responsive and not breathing.

Stay With the Person

Help them feel more comfortable until emergency help arrives.

How To Recognize An Opioid Overdose Emergency

Here’s what to look for and what to do if you suspect an opioid overdose emergency.

See More Resources ›

References

  1. CDC, “Preventing an Opioid Overdose,” https://www.cdc.gov/drugoverdose/pdf/patients/preventing-an-opioid-overdose-tip-card-a.pdf, Accessed June 1, 2021.
  2. NIDA 2021, “Prescription Opioid DrugFacts,”  https://www.drugabuse.gov/publications/drugfacts/prescription-opioids, Accessed June 1, 2021.
  3. National Safety Council, “Addressing the Opioid Crisis.” https://www.nsc.org/home-safety/safety-topics/opioids, Accessed May 3, 2021.
  4. Mayo Clinic Staff 2020, “Medication errors: Cut your risk with these tips,” https://www.mayoclinic.org/healthy-lifestyle/consumer-health/in-depth/medication-errors/art-20048035, Accessed May 3, 2021.
  5. HHS 2019. “Non-fatal opioid overdose and associated health outcomes,” https://aspe.hhs.gov/basic-report/non-fatal-opioid-overdose-and-associated-health-outcomes-final-summary-report, Accessed May 2021.
  6. CDC, 2020, “Overdose Deaths and the Involvement of Illicit Drugs.” https://www.cdc.gov/drugoverdose/featured-topics/VS-overdose-deaths-illicit-drugs.html, Accessed September 15, 2021.

Important Safety Information About KLOXXADO® (naloxone HCl) Nasal Spray 8 mg

Contraindications

Hypersensitivity to naloxone hydrochloride or to any of the other ingredients

Warnings and Precautions

  • Use KLOXXADO® right away if you suspect an opioid overdose emergency, even if you are not sure, because an opioid overdose emergency can cause severe injury or death. Signs and symptoms of an opioid overdose emergency may include:
    • Unusual sleepiness; you are not able to awaken the person with a loud voice or by rubbing firmly on the middle of their chest (sternum).
    • Breathing problems, including slow or shallow breathing in someone difficult to awaken or who looks like they are not breathing.
    • The black circle in the center of the colored part of the eye (pupil) is very small (sometimes called “pinpoint pupils”) in someone difficult to awaken.
  • Family members, caregivers or other people who may have to use KLOXXADO® in an opioid overdose emergency should know where KLOXXADO® is stored and how to give KLOXXADO® before an opioid overdose emergency happens.
  • Get emergency medical help right away after using the first dose of KLOXXADO®. Rescue breathing or CPR (cardiopulmonary resuscitation) may be needed while waiting for emergency medical help.
  • The signs and symptoms of an opioid overdose emergency can return after KLOXXADO® is given. If this happens, give another dose after 2 to 3 minutes, using a new KLOXXADO® device, alternating nostrils, and watch the person closely until emergency medical help arrives.
  • Do not use KLOXXADO® if you are allergic to naloxone hydrochloride or any of the ingredients in KLOXXADO®.
  • KLOXXADO® can cause sudden and severe opioid withdrawal, the symptoms of which may include body aches, diarrhea, increased heart rate, fever, runny nose, sneezing, goosebumps, sweating, yawning, nausea or vomiting, nervousness, restlessness or irritability, shivering or trembling, stomach cramps, weakness and increased blood pressure.
  • In infants under 4 weeks old who have been receiving opioids regularly, sudden opioid withdrawal may be life-threatening if not treated the right way. Signs and symptoms include: seizures, crying more than usual, and increased reflexes.
  • Tell your doctor about all of your medical conditions before using KLOXXADO®, including if you have heart problems, are pregnant or plan to become pregnant, are breastfeeding or plan to breastfeed.
  • Tell your doctor about all of the medicines you take, including prescription and over-the-counter medicines, drugs, vitamins and herbal supplements.

Side Effects

The following serious side effect is discussed in the full Prescribing Information for KLOXXADO®:

  • Sudden and Severe Opioid Withdrawal

Symptoms of sudden and severe opioid withdrawal resulting from the use of KLOXXADO® in someone regularly using opioids include: body aches, diarrhea, increased heart rate, fever, runny nose, sneezing, goosebumps, sweating, yawning, nausea or vomiting, nervousness, restlessness or irritability, shivering or trembling, stomach cramps, weakness and increased blood pressure.

Infants may have seizures, cry more than normal and have increased reflexes.

Some people may become aggressive after abrupt reversal of opioid overdose.

In two clinical studies, a total of 47 healthy adult volunteers were exposed to a single dose of KLOXXADO®, one spray in one nostril. Side effects were reported in two subjects for each of the following: abdominal pain, asthenia, dizziness, headache, nasal discomfort, and presyncope.

These are not all of the possible side effects of KLOXXADO®. Contact your doctor for medical advice about side effects.

Pregnancy, Infancy and Breastfeeding, Children

Tell your doctor if you are pregnant or plan to become pregnant. If you are pregnant and opioid dependent, use of KLOXXADO® may cause withdrawal symptoms in you and your unborn baby. A healthcare provider should monitor you and your unborn baby right away after you use KLOXXADO®.

There is no information regarding the presence of naloxone in human milk, the effects of naloxone on the breastfed infant or on milk production.

If the primary concern is an infant at risk of an overdose, consider whether other naloxone-containing products may be more appropriate.

KLOXXADO® nasal spray is safe and effective in children for known or suspected opioid overdose.

Dosage and Administration

Do not attempt to prime or test-fire the device. Each KLOXXADO® Nasal Spray contains only 1 dose of medicine and cannot be reused. Read the “instructions for use” at the end of the Prescribing Information and Medication Guide for detailed information about the right way to use KLOXXADO® Nasal Spray.

Storage and Handling

Store KLOXXADO® at room temperature between 68°F to 77°F (20°C to 25°C). Do not expose to temperatures below 41°F (5°C) or above 104°F (40°C). Do not freeze KLOXXADO®. Keep KLOXXADO® in its box until ready to use. Protect from light. Replace KLOXXADO® before the expiration date on the box. Keep KLOXXADO® and all medicines out of the reach of children.

For more information, please see the full Prescribing Information and Medication Guide.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit https://www.fda.gov/medwatch or call 1-800-FDA-1088.

Distributed by: Hikma Specialty USA Inc., Columbus, OH 43228.

This website is intended for U.S. audiences
Customer Service: Phone 1-877-259-6893 | Email

© Hikma Specialty USA Inc. All rights reserved.
NARCAN® is a registered trademark of Emergent Operations Ireland Limited.

KLOXXADO®️ is a registered trademark of Hikma Pharmaceuticals USA Inc.
The brand statement “Better Health. Within Reach. Every Day.” is a registered trademark of Hikma Pharmaceuticals PLC.

HK-1266-v3

June 2023

This website uses cookies and third party services. Please see our cookie policy and privacy policy for more information. OK
Go to Top
Read More...

Important Safety Information About KLOXXADO® (naloxone HCl) Nasal Spray 8 mg

Contraindications